Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Biofrontera (BFRI) Equity Ratio: 2020-2024

Historic Equity Ratio for Biofrontera (BFRI) over the last 5 years, with Dec 2024 value amounting to 0.20.

  • Biofrontera's Equity Ratio fell 156.06% to -0.17 in Q3 2025 from the same period last year, while for Sep 2025 it was -0.17, marking a year-over-year decrease of 156.06%. This contributed to the annual value of 0.20 for FY2024, which is 16.89% up from last year.
  • Per Biofrontera's latest filing, its Equity Ratio stood at 0.20 for FY2024, which was up 16.89% from 0.17 recorded in FY2023.
  • Biofrontera's 5-year Equity Ratio high stood at 0.47 for FY2022, and its period low was 0.17 during FY2023.
  • For the 3-year period, Biofrontera's Equity Ratio averaged around 0.28, with its median value being 0.20 (2024).
  • Per our database at Business Quant, Biofrontera's Equity Ratio skyrocketed by 120.27% in 2022 and then crashed by 63.43% in 2023.
  • Over the past 5 years, Biofrontera's Equity Ratio (Yearly) stood at 0.24 in 2020, then fell by 11.76% to 0.21 in 2021, then soared by 120.27% to 0.47 in 2022, then slumped by 63.43% to 0.17 in 2023, then increased by 16.89% to 0.20 in 2024.